Results 21 to 30 of about 539,134 (347)

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202

open access: yesFrontiers in Immunology, 2022
The age of allogeneic hematopoietic cell transplant (HCT) donors and their hematopoietic cell telomere length (TL) might affect recipients’ outcomes. Our goals were to examine the possible effect of these donors’ factors on the recipients’ hematopoietic ...
Tsung-Po Lai   +12 more
doaj   +1 more source

Gender Distribution and Reasons for Donor Deferral in Blood Donors at a Tertiary Healthcare Centre, Kerala, India: A Cross-sectional Study [PDF]

open access: yesNational Journal of Laboratory Medicine, 2023
Introduction: One of the primary responsibilities of the blood bank is to provide safe blood to patients. Blood donors are screened before blood donation and deferred from donating if they have diseases or conditions that may affect blood quality or lead
DEEPA NARAYANAN, ARCHANA RAJAN, V BINDU
doaj   +1 more source

Selection strategies for the development of maize introgression populations [PDF]

open access: yes, 2014
Introgression libraries are valuable resources for QTL detection and breeding, but their development is costly and time-consuming. Selection strategies for the development of introgression populations with a limited number of individuals and high ...
Falke, Karen Christin   +5 more
core   +6 more sources

Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis

open access: yesFrontiers in Oncology, 2022
BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for various hematologic disorders. Alternative donor strategies such as mismatched unrelated donors (MMUD) offer the option of HSCT to patients lacking ...
Muhammad Umair Mushtaq   +15 more
doaj   +1 more source

Donor selection for allogenic hemopoietic stem cell transplantation: clinical and ethical considerations [PDF]

open access: yes, 2017
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for many diseases. Stem cells may be obtained from different sources: mobilized peripheral blood stem cells, bone marrow, and umbilical cord blood.
La Russa, Raffaele   +5 more
core   +4 more sources

Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria

open access: yesBMC Health Services Research, 2019
Background Blood transfusion is a life-saving intervention. However, the safety of the donor and the recipient is paramount. This study was aimed at determining the blood donation deferral pattern of University of Calabar Teaching Hospital.
Henshaw Uchechi Okoroiwu   +1 more
doaj   +1 more source

HLA antibodies and donor selection [PDF]

open access: yes, 2010
In spite of Anti-HLA antibodies being associated to rejection in solid organs transplantation, this correlation has not been well established yet in allogenic bone marrow transplantation.Recent studies in the literature have demonstrated that engraftment
Alencar, Iracema S. B.   +9 more
core   +1 more source

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles. [PDF]

open access: yes, 2016
KIR2DL2 and KIR2DL3 segregate as alleles of a single locus in the centromeric motif of the killer cell immunoglobulin-like receptor (KIR) gene family. Although KIR2DL2/L3 polymorphism is known to be associated with many human diseases and is an important
Bao, Ju   +5 more
core   +1 more source

Selecting and Screening Donors [PDF]

open access: yes, 2013
Oocyte donation was originally established in 1983 as a treatment option for younger women with premature ovarian failure and for women with severe pelvic disease whose ovaries, as a result, were surgically inaccessible. The indications for donor oocyte in vitro fertilization (IVF) have now expanded to include not only women with hypergonadotropic ...
Brian A. Levine   +2 more
openaire   +1 more source

Donor lung selection criteria and surgical application at University of Pittsburgh [PDF]

open access: yes, 2012
Lung transplantation is the standard treatment for patients with end-stage lung disease. Unfortunately scarce source of donor organs, particularly in lungs, limits this selected treatment to very few recipients each year.
Sareyyupoglu, B, Toyoda, Y, Yücel, O
core   +1 more source

Home - About - Disclaimer - Privacy